220 related articles for article (PubMed ID: 24879900)
21. Mechanistic Insights into the Pharmacological Significance of Silymarin.
Wadhwa K; Pahwa R; Kumar M; Kumar S; Sharma PC; Singh G; Verma R; Mittal V; Singh I; Kaushik D; Jeandet P
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014565
[TBL] [Abstract][Full Text] [Related]
22. Silymarin Constituents Enhance ABCA1 Expression in THP-1 Macrophages.
Wang L; Rotter S; Ladurner A; Heiss EH; Oberlies NH; Dirsch VM; Atanasov AG
Molecules; 2015 Dec; 21(1):E55. PubMed ID: 26729088
[TBL] [Abstract][Full Text] [Related]
23. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW; Lin LC; Tsai TH
J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
[TBL] [Abstract][Full Text] [Related]
24. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin.
Islam A; Mishra A; Siddiqui MA; Siddiquie S
Drug Res (Stuttg); 2021 Nov; 71(9):489-503. PubMed ID: 34318464
[TBL] [Abstract][Full Text] [Related]
25. Silymarin protects against radiocontrast-induced nephropathy in mice.
de Souza Santos V; Peters B; Côco LZ; Alves GM; de Assis ALEM; Nogueira BV; Meyrelles SS; Porto ML; Vasquez EC; Campagnaro BP; Pereira TMC
Life Sci; 2019 Jul; 228():305-315. PubMed ID: 31047898
[TBL] [Abstract][Full Text] [Related]
26. Interaction of isolated silymarin flavonolignans with iron and copper.
Tvrdý V; Catapano MC; Rawlik T; Karlíčková J; Biedermann D; Křen V; Mladěnka P; Valentová K
J Inorg Biochem; 2018 Dec; 189():115-123. PubMed ID: 30245273
[TBL] [Abstract][Full Text] [Related]
27. Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation.
Tsai MJ; Liao JF; Lin DY; Huang MC; Liou DY; Yang HC; Lee HJ; Chen YT; Chi CW; Huang WC; Cheng H
Neurochem Int; 2010 Dec; 57(8):867-75. PubMed ID: 20868716
[TBL] [Abstract][Full Text] [Related]
28. Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.
Mastron JK; Siveen KS; Sethi G; Bishayee A
Anticancer Drugs; 2015 Jun; 26(5):475-86. PubMed ID: 25603021
[TBL] [Abstract][Full Text] [Related]
29. Silybin and silymarin--new effects and applications.
Kren V; Walterová D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):29-41. PubMed ID: 16170386
[TBL] [Abstract][Full Text] [Related]
30. Differential Effects of the Flavonolignans Silybin, Silychristin and 2,3-Dehydrosilybin on
Hrčková G; Kubašková TM; Benada O; Kofroňová O; Tumová L; Biedermann D
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453549
[No Abstract] [Full Text] [Related]
31. [Hepatoprotective properties of silymarin].
Matveev AV; Koniaeva EI; Kurchenko VP; Shchekatikhina AS
Eksp Klin Gastroenterol; 2011; (2):130-5. PubMed ID: 21560654
[TBL] [Abstract][Full Text] [Related]
32. Silybin and silymarin--new and emerging applications in medicine.
Gazák R; Walterová D; Kren V
Curr Med Chem; 2007; 14(3):315-38. PubMed ID: 17305535
[TBL] [Abstract][Full Text] [Related]
33. Differential accumulation of silymarin induced by exposure of Silybum marianum L. callus cultures to several spectres of monochromatic lights.
Younas M; Drouet S; Nadeem M; Giglioli-Guivarc'h N; Hano C; Abbasi BH
J Photochem Photobiol B; 2018 Jul; 184():61-70. PubMed ID: 29803074
[TBL] [Abstract][Full Text] [Related]
34. [Silibinin and its hepatoprotective action from the perspective of a toxicologist].
Kostek H; Szponar J; Tchórz M; Majewska M; Lewandowska-Stanek H
Przegl Lek; 2012; 69(8):541-3. PubMed ID: 23243923
[TBL] [Abstract][Full Text] [Related]
35. Linear regression analysis of silychristin A, silybin A and silybin B contents in
AbouZid SF; Ahmed HS; Abd El Mageed AMA; Moawad AS; Owis AI; Chen SN; Nachtergael A; McAlpine JB; Friesen JB; Pauli GF
Nat Prod Res; 2020 Jan; 34(2):305-310. PubMed ID: 30488719
[TBL] [Abstract][Full Text] [Related]
36. Silychristin: Skeletal Alterations and Biological Activities.
Biedermann D; Buchta M; Holečková V; Sedlák D; Valentová K; Cvačka J; Bednárová L; Křenková A; Kuzma M; Škuta C; Peikerová Ž; Bartůněk P; Křen V
J Nat Prod; 2016 Dec; 79(12):3086-3092. PubMed ID: 28006905
[TBL] [Abstract][Full Text] [Related]
37. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
38. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review.
Gillessen A; Schmidt HH
Adv Ther; 2020 Apr; 37(4):1279-1301. PubMed ID: 32065376
[TBL] [Abstract][Full Text] [Related]
39. Silymarin and milk thistle extract may prevent the progression of diabetic nephropathy in streptozotocin-induced diabetic rats.
Vessal G; Akmali M; Najafi P; Moein MR; Sagheb MM
Ren Fail; 2010 Jul; 32(6):733-9. PubMed ID: 20540643
[TBL] [Abstract][Full Text] [Related]
40. Enhanced production of silymarin by Ag+ elicitor in cell suspension cultures of Silybum marianum.
Ashtiani SR; Hasanloo T; Bihamta MR
Pharm Biol; 2010 Jun; 48(6):708-15. PubMed ID: 20645746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
